🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The overarching goal of this study is to develop PET/MR techniques for the ...
Status
Active Not Recruiting
Location
NYU Langone Health
Start Date
2022-02-15
Trial ID
NCT05615415
Treatments Being Tested
The aim of this project is to test the utility of The Gene Z device (as of ...
Status
Recruiting
Location
University of Michigan Health/Sparrow (name change only)
Start Date
2015-06
Trial ID
NCT01904188
This research clinical trial is studying the creation and administration of...
Status
Terminated
Location
Boston Children's Hospital
Start Date
2020-01-29
Trial ID
NCT04239040
Treatments Being Tested
This phase II clinical trial studies how well craniospinal irradiation (CSI...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-03-03
Trial ID
NCT06518057
A prospective and retrospective cohort study of about five years will be pe...
Status
Recruiting
Location
IRCCS Neuromed
Start Date
2017-11-22
Trial ID
NCT03217396
Treatments Being Tested
This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-06
Trial ID
NCT07219147
This phase I trial tests the safety and side effects of B-cell activating f...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2027-04-17
Trial ID
NCT07758673
Treatments Being Tested
This phase I/II trial tests the safety, side effects best dose and effect o...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-06-23
Trial ID
NCT07468136
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662